Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
A systematic review of the cardiovascular risk of inhaled anticholinergics in patients with COPD
International Journal of COPD, 07/01/09
Hilleman DE et al. - The long-term use of inhaled anticholinergic agents has recently been suggested to be associated with an excess risk of adverse cardiovascular (CV) outcomes in patients with COPD. The relative risks for serious CV events, heart failure, and myocardial infarction were all significantly lower with tiotropium than placebo.
Today in COPD...keeping you current
Receive free subspecialty "5-minute updates" via email
Chronic Obstructive Pulmonary Disease: Role of Bacteria and Updated Guide to Antibacterial Selection in the Older Patient
Drugs & Aging, 11/25/09
Hemodynamic and Gas Exchange Effects of Sildenafil in Patients with COPD and Pulmonary Hypertension
American Journal of Respiratory and Critical Care Medicine, 10/30/09
The ADMIT series - Issues in Inhalation Therapy. 4) How to choose inhaler devices for the treatment of COPD
Primary Care Respiratory Journal, 11/05/09
Sponsor
Article Search
Sponsor


See Latest Articles


